tiprankstipranks
Advertisement
Advertisement
Adlai Nortye Ltd (ADR) trading halted, volatility trading pause
PremiumThe FlyAdlai Nortye Ltd (ADR) trading halted, volatility trading pause
2M ago
Adlai Nortye Reshapes Top Leadership as President Retires and R&D Chief Steps Up
Premium
Company Announcements
Adlai Nortye Reshapes Top Leadership as President Retires and R&D Chief Steps Up
2M ago
Leerink bullish on Adlai Nortye, initiates with an Outperform
Premium
The Fly
Leerink bullish on Adlai Nortye, initiates with an Outperform
2M ago
Adlai Nortye upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyAdlai Nortye upgraded to Buy from Neutral at H.C. Wainwright
4M ago
Adlai Nortye Doses First Patient in Global Phase 1 Trial of Pan-RAS Inhibitor AN9025
Premium
Company Announcements
Adlai Nortye Doses First Patient in Global Phase 1 Trial of Pan-RAS Inhibitor AN9025
4M ago
Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline
Premium
Company Announcements
Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline
4M ago
Adlai Nortye Narrows First-Half 2025 Loss as Oncology Pipeline Advances
PremiumCompany AnnouncementsAdlai Nortye Narrows First-Half 2025 Loss as Oncology Pipeline Advances
5M ago
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China
Premium
Company Announcements
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China
5M ago
Adlai Nortye enters exclusive license agreement with ASK Pharm for AN9025
Premium
The Fly
Adlai Nortye enters exclusive license agreement with ASK Pharm for AN9025
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100